Ionis Says EU Committee Recommends Expanded Tryngolza Approval
Ionis Pharmaceuticals said the European Medicines Agency’s Committee for Medicinal Products for Human Use recommended expanded approval of Tryngolza for people with severe hypertriglyceridemia.
Ionis Pharmaceuticals said a key European regulatory committee has recommended expanding approval of its Tryngolza drug for people with severe hypertriglyceridemia. The company said Friday that the recommendation came from the European Medicines Agency’s Committee for Medicinal Products for Human…